https://feeds.newsfilecorp.com/company/6123 Latest news from Biocure Technology Inc., as distributed by TMX Newsfile. en CopyRight (c) 2026, Newsfile Corp. All Rights Reserved. office@newsfilecorp.com (Newsfile Corp.) office@newsfilecorp.com (Newsfile Corp.) Mon, 09 Mar 2026 08:04:42 -0400 https://www.newsfilecorp.com/images/newswire/customer-logos/6123.jpg https://feeds.newsfilecorp.com/company/6123 https://www.newsfilecorp.com/release/180925/Biocure-Technology-Inc.-Enters-into-Exclusive-Letter-Agreement-to-Acquire-Atriva-Therapeutics-GmbH-in-Reverse-Takeover-Transaction Vancouver, British Columbia--(Newsfile Corp. - September 18, 2023) - Biocure Technology Inc. (CSE: CURE) ("CURE" or the "Company") announces that it has entered into an exclusive letter agreement dated September 8, 2023 with Atriva Therapeutics GmbH. ("Atriva") whereby the Company will acquire all of the issued and outstanding securities of Atriva (the "Transaction"). The Transaction will be a business combination completed by way of a share exchange, share purchase, amalgamation, arrangement,...<img src="https://api.newsfilecorp.com/newsinfo/180925/156" id="156" width="2" height="2" style="width: 1px; height: 1px;border: 0px solid;" /> Mon, 18 Sep 2023 09:00:00 -0400 en https://www.newsfilecorp.com/release/180925